U.S. House Passes Drug Pricing Bill
Dec. 13, 2019 — A U.S. House Democrat invoice that may give Medicare the authority to barter prescription drug costs and supply new advantages for seniors used to be handed Thursday in a 230-192 vote alongside birthday celebration traces.
However, the invoice has no probability of being handed by way of the Republican-controlled Senate and the White House has threatened to veto it, the Associated Press reported.
The AARP is likely one of the teams that strengthen the invoice, whilst the pharmaceutical business strongly opposes it.
House Speaker Nancy Pelosi’s invoice would restrict Medicare sufferers’ out-of-pocket prices for medications to $2,000 a yr and create protection for dental care, listening to and imaginative and prescient by way of the usage of the $360 billion of anticipated 10-year financial savings from decrease drug prices, the AP reported.
The invoice “is a serious proposal but everyone knows that the Senate isn’t going to go for it,” consistent with John Rother, CEO of the National Coalition on Health, a gaggle that represents well being care business teams and shoppers.
“It is about legislating, but even more it’s about establishing a platform that Democrats can run on going into the next election cycle and lays the groundwork for legislative activity in 2021,” Rother instructed the AP.
Pelosi stated her invoice would ship on Donald Trump’s promise all through the 2016 presidential marketing campaign to “negotiate like crazy” to decrease prescription drug costs for Medicare recipients.
As president, Trump has sponsored clear of the promise, the AP reported.